EP Patent

EP3170829A1 — Novel salt of tenofovir disoproxil

Assigned to JW Pharmaceutical Corp · Expires 2017-05-24 · 9y expired

What this patent protects

Disclosed is a novel tenofovir disoproxil edisylate salt having the structure of Chemical Formula 1.

USPTO Abstract

Disclosed is a novel tenofovir disoproxil edisylate salt having the structure of Chemical Formula 1.

Drugs covered by this patent

Patent Metadata

Patent number
EP3170829A1
Jurisdiction
EP
Classification
—
Expires
2017-05-24
Drug substance claim
No
Drug product claim
No
Assignee
JW Pharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.